Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers
- PMID: 20507946
- PMCID: PMC2940065
- DOI: 10.1378/chest.08-2991
Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers
Abstract
Background: Survival outcomes of never smokers with non-small cell lung cancer (NSCLC) who undergo surgery are poorly characterized. This investigation compared surgical outcomes of never and current smokers with NSCLC.
Methods: This investigation was a single-institution retrospective study of never and current smokers with NSCLC from 1975 to 2004. From an analytic cohort of 4,546 patients with NSCLC, we identified 724 never smokers and 3,822 current smokers. Overall, 1,142 patients underwent surgery with curative intent. For survival analysis by smoking status, hazard ratios (HRs) were estimated using Cox proportional hazard modeling and then further adjusted by other covariates.
Results: Never smokers were significantly more likely than current smokers to be women (P < .01), older (P < .01), and to have adenocarcinoma (P < .01) and bronchioloalveolar carcinoma (P < .01). No statistically significant differences existed in stage distribution at presentation for the analytic cohort (P = .35) or for the subgroup undergoing surgery (P = .24). The strongest risk factors of mortality among patients with NSCLC who underwent surgery were advanced stage (adjusted hazard ratio, 3.43; 95% CI, 2.32-5.07; P < .01) and elevated American Society of Anesthesiologists classification (adjusted hazard ratio, 2.18; 95% CI, 1.40-3.40; P < .01). The minor trend toward an elevated risk of death on univariate analysis for current vs never smokers in the surgically treated group (hazard ratio, 1.20; 95% CI, 0.98-1.46; P = .07) was completely eliminated when the model was adjusted for covariates (P = .97).
Conclusions: Our findings suggest that smoking status at time of lung cancer diagnosis has little impact on the long-term survival of patients with NSCLC, especially after curative surgery. Despite different etiologies between lung cancer in never and current smokers the prognosis is equally dismal.
Similar articles
-
Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.Acta Oncol. 2019 Nov;58(11):1618-1627. doi: 10.1080/0284186X.2019.1638521. Epub 2019 Aug 2. Acta Oncol. 2019. PMID: 31373239
-
Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.Thorac Cardiovasc Surg. 2016 Sep;64(6):507-14. doi: 10.1055/s-0035-1558995. Epub 2015 Sep 14. Thorac Cardiovasc Surg. 2016. PMID: 26366891
-
Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).J Thorac Oncol. 2007 Sep;2(9):827-30. doi: 10.1097/JTO.0b013e318145af79. J Thorac Oncol. 2007. PMID: 17805060
-
Nonsmall cell lung cancer in never smokers.Curr Opin Oncol. 2009 Mar;21(2):99-104. doi: 10.1097/CCO.0b013e328321049e. Curr Opin Oncol. 2009. PMID: 19532009 Review.
-
The evolution of the treatment of non-small cell lung cancer: A shift in surgical paradigm to a more individualized approach.J Thorac Cardiovasc Surg. 2025 Mar;169(3):737-744.e2. doi: 10.1016/j.jtcvs.2024.07.040. Epub 2024 Jul 25. J Thorac Cardiovasc Surg. 2025. PMID: 39067812 Review.
Cited by
-
Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?Nicotine Tob Res. 2016 Dec;18(12):2216-2224. doi: 10.1093/ntr/ntw189. Epub 2016 Aug 18. Nicotine Tob Res. 2016. PMID: 27613928 Free PMC article.
-
Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.Cancer Biol Ther. 2019;20(5):680-691. doi: 10.1080/15384047.2018.1550570. Epub 2018 Dec 27. Cancer Biol Ther. 2019. PMID: 30590988 Free PMC article.
-
Impact of smoking on mortality of patients with non-small cell lung cancer.Thorac Cancer. 2014 Jan;5(1):43-9. doi: 10.1111/1759-7714.12051. Epub 2014 Jan 2. Thorac Cancer. 2014. PMID: 26766971 Free PMC article.
-
Conditional survival analysis of patients with resected non-small cell lung cancer.JTCVS Open. 2023 Sep 18;16:948-959. doi: 10.1016/j.xjon.2023.09.010. eCollection 2023 Dec. JTCVS Open. 2023. PMID: 38204712 Free PMC article.
-
Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.Cancer Med. 2023 May;12(9):10563-10574. doi: 10.1002/cam4.5791. Epub 2023 Mar 23. Cancer Med. 2023. PMID: 36952375 Free PMC article.
References
-
- American Cancer Society Estimated cancer deaths. http://www.cancer.org/docroot/CRI/content/CRI_2_2_1x_How_Many_People_Get.... Accessed January 30, 2009.
-
- Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129–2139. - PubMed
-
- Paez JG, Jänne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304(5676):1497–1500. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical